The restoration of DAB2IP expression by 5-acetazolamide-2-cytosine deoxyriboside (5azaDC, DNA demethylating agent) supported the epigenetic regulation of breast cancer progression (Dote et al. 2004). The gene discussed is DAB2IP; the disease is breast cancer.